Delivery Order SPE2DX22D0010-SPE2D826FAH19
- Not listed
- This delivery order, awarded on October 13, 2025, represents a firm fixed-price contract valued at $9,005.50 issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is non-set-aside and competitively awarded, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 2026. The place of performance is...
- This delivery order, awarded on October 13, 2025, represents a $56,056 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is expected to conclude by October 14, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and represents a child delivery order under...
- This delivery order, awarded on October 13, 2025, represents a $14.2K firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which concludes on October 14, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen will perform work at its corporate office location in Conshohocken, Pennsylvania, serving as a critical pharmaceutical distributor for federal medical...
- This delivery order, issued on October 2, 2025, represents a $7,665.27 firm fixed-price contract awarded to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is neither set-aside nor restricted, has an ultimate completion date of October 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award is a child action stemming from...
- This delivery order, awarded October 13, 2025, represents a $10,861.90 firm fixed-price award to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) through the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The delivery order is...
- This delivery order, awarded October 6, 2025, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) represents a $16,203.21 firm fixed-price award from the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract, which is classified as a child order under a larger indefinite delivery vehicle, is scheduled for completion by October 7, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made...
- This delivery order, awarded on October 13, 2025, represents a $15,677.08 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Department's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. The award is non-competitive and carries an ultimate completion date of...
- This delivery order, awarded on October 13, 2025, represents a $41,482.50 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of...
- This delivery order, awarded on October 2, 2025, represents a $1.44 million firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which must be completed by October 3, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- This delivery order, awarded on October 4, 2025, represents a $3,016.26 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Department's Medical Supply Chain division. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. This delivery order carries no set-aside designation and was competitively...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAH19Delivery Order
This delivery order, awarded on October 13, 2025, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) represents a $13,358.70 firm fixed-price award from the Defense Logistics Agency's Medical Supply Chain division. The contract, which is a child order under a larger Indefinite Delivery Contract vehicle, is scheduled for completion by October 14, 2025, and will be performed at the company's Conshohocken, Pennsylvania location. This award was competitively awarded with no set-aside designation and reflects AmerisourceBergen's continued role as a critical pharmaceutical distributor for federal medical procurement needs. AmerisourceBergen Drug Corp's delivery order falls under the company's broader $999,999,999 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains—to support military healthcare programs and other federal customers including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates versatility in fulfilling diverse medical supply requirements ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 10/13/25 |